2012
DOI: 10.1016/j.jconrel.2011.12.021
|View full text |Cite
|
Sign up to set email alerts
|

Administration, distribution, metabolism and elimination of polymer therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
187
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 266 publications
(192 citation statements)
references
References 163 publications
2
187
0
Order By: Relevance
“…Generally, large molecules of water soluble synthetic polymers can remain in tissue and return to the blood stream by lymphatic circulation. 48 If the molecules are under the glomerular threshold, they will be eliminated by glomerular filtration in the kidneys and will be excreted in the urine. The polymeric chains larger than the renal threshold may be taken by the mononuclear phagocyte system, also known as reticuloendothelial system, as a foreign material.…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Generally, large molecules of water soluble synthetic polymers can remain in tissue and return to the blood stream by lymphatic circulation. 48 If the molecules are under the glomerular threshold, they will be eliminated by glomerular filtration in the kidneys and will be excreted in the urine. The polymeric chains larger than the renal threshold may be taken by the mononuclear phagocyte system, also known as reticuloendothelial system, as a foreign material.…”
Section: Figurementioning
confidence: 99%
“…The polymeric chains larger than the renal threshold may be taken by the mononuclear phagocyte system, also known as reticuloendothelial system, as a foreign material. [48][49][50] After phagocytosis, the synthetic polymer will be destroyed or sequestered in mononuclear phagocyte system organs. Also the pathway of excreting PEDOT:PSS can be a xenobiotic metabolism in the liver.…”
Section: Figurementioning
confidence: 99%
“…On the other hand and as the main drawback, some specific amino acid sequences or homopeptides can trigger disease cascades or their accumulation as aggregates may result in disease promotion, i.e., neurodegeneration disorders. Therefore, this possible impaired toxicity must be studied, and precise control of the selected amino acid composition and the final macromolecular architecture adopted have been defined as crucial design features [35][36][37][38]. It has to be emphasised that there is a growing effort to better understand the structure-activity relationships in order to better define safety and efficacy of these novel therapeutics [15].…”
Section: Introductionmentioning
confidence: 99%
“…The protein corona therefore might interfere with cellular uptake and modify the interaction between particles themselves. Likely, specific proteins of the protein corona influence the tendency of NPs to form aggregates which in turn also influences their biodistribution in vivo [6][7][8].…”
Section: Introductionmentioning
confidence: 99%